Healthcare Value Capital as of June 30, 2014
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 29 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 16.4 | $20M | 100k | 195.72 | |
| Ultra Short Russell 2000 | 11.7 | $14M | 325k | 43.04 | |
| Albany Molecular Research | 10.1 | $12M | 598k | 20.12 | |
| iShares Russell 2000 Index (IWM) | 10.0 | $12M | 100k | 118.81 | |
| AstraZeneca (AZN) | 6.2 | $7.4M | 100k | 74.31 | |
| Biosante Pharmaceuticals (ANIP) | 5.8 | $6.9M | 199k | 34.44 | |
| Teva Pharmaceutical Industries (TEVA) | 5.7 | $6.8M | 130k | 52.42 | |
| Auxilium Pharmaceuticals | 5.5 | $6.6M | 330k | 20.06 | |
| Proshares Tr ultsh nasd biot | 4.8 | $5.7M | 400k | 14.24 | |
| Quest Diagnostics Incorporated (DGX) | 3.8 | $4.5M | 77k | 58.69 | |
| Merck & Co (MRK) | 3.7 | $4.5M | 77k | 57.84 | |
| Pfizer (PFE) | 3.7 | $4.5M | 150k | 29.68 | |
| Sanofi-Aventis SA (SNY) | 2.6 | $3.1M | 58k | 53.17 | |
| Supernus Pharmaceuticals (SUPN) | 1.8 | $2.2M | 200k | 10.95 | |
| Impax Laboratories | 1.3 | $1.5M | 50k | 30.00 | |
| Sorrento Therapeutics (SRNEQ) | 1.2 | $1.4M | 205k | 6.75 | |
| Sunesis Pharmaceuticals | 0.8 | $978k | 150k | 6.52 | |
| Kindred Biosciences | 0.8 | $932k | 50k | 18.64 | |
| Sucampo Pharmaceuticals | 0.6 | $667k | 97k | 6.90 | |
| Fibrocell Science | 0.5 | $630k | 158k | 3.99 | |
| Cempra | 0.5 | $537k | 50k | 10.74 | |
| Zogenix | 0.4 | $503k | 250k | 2.01 | |
| Galmed Pharmaceuticals | 0.4 | $487k | 50k | 9.74 | |
| Ariad Pharmaceuticals | 0.4 | $478k | 75k | 6.37 | |
| Biota Pharmaceuticals | 0.3 | $415k | 146k | 2.85 | |
| Rigel Pharmaceuticals (RIGL) | 0.3 | $363k | 100k | 3.63 | |
| Celsion Corporation | 0.3 | $347k | 100k | 3.47 | |
| D Stemline Therapeutics | 0.2 | $242k | 17k | 14.70 | |
| Cytokinetics (CYTK) | 0.2 | $199k | 42k | 4.78 |
